SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

28 May 2025 Evaluate
A decrease in the sales to Rs. 7680.26 millions was observed for the quarter ended March 2025. The sales stood at Rs. 9401.91 millions during the similar quarter previous year.Net profit declined -3.25% to Rs. 940.54 millions from Rs. 972.16 millions.The company reported a degrowth in operating Profit to 1474.00 millions from 1927.06 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 7680.26 9401.91 -18.31 30301.63 37550.91 -19.31 30301.63 37550.91 -19.31
Other Income 304.85 34.25 790.07 406.80 57.77 604.17 406.80 57.77 604.17
PBIDT 1474.00 1927.06 -23.51 6054.84 8071.37 -24.98 6054.84 8071.37 -24.98
Interest 134.87 197.85 -31.83 627.80 719.98 -12.80 627.80 719.98 -12.80
PBDT 1646.63 1729.21 -4.78 5734.54 7351.39 -21.99 5734.54 7351.39 -21.99
Depreciation 379.73 364.10 4.29 1462.30 1438.48 1.66 1462.30 1438.48 1.66
PBT 1266.90 1365.11 -7.19 4272.24 5912.91 -27.75 4272.24 5912.91 -27.75
TAX 326.36 392.95 -16.95 1078.88 1553.73 -30.56 1078.88 1553.73 -30.56
Deferred Tax -61.82 -34.21 80.71 -19.91 47.68 -141.76 -19.91 47.68 -141.76
PAT 940.54 972.16 -3.25 3193.36 4359.18 -26.74 3193.36 4359.18 -26.74
Equity 242.54 242.37 0.07 242.54 242.37 0.07 242.54 242.37 0.07
PBIDTM(%) 19.19 20.50 -6.36 19.98 21.49 -7.04 19.98 21.49 -7.04

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×